Ex parte WANG - Page 5




                     Appeal No. 93-3228                                                                                                                                                
                     Application 07/796,023                                                                                                                                            



                                In construing the phrase “consisting essentially of” in                                                                                                
                     appellant’s claims, it is necessary and proper to determine                                                                                                       
                     whether the specification reasonably supports a construction                                                                                                      
                     which would include the materials of the cited prior art.  See                                                                                                    
                     In re Herz, 537 F.2d 549, 551, 190 USPQ 461, 463 (CCPA 1976).                                                                                                     
                     Appellant’s specification, under the heading “Summary of the                                                                                                      
                     Invention”, states that the invention is that “lipid powder is                                                                                                    
                     simply admixed with a suitable amount of bioactive                                                                                                                
                     macromolecule, and compressed into a disc or rod without any                                                                                                      
                     other components.” (specification, sentence bridging pages 7                                                                                                      
                     and 8, emphasis added).  From the remainder of appellant’s                                                                                                        
                     specification, including the examples, there is no disclosure                                                                                                     
                     or teaching that any components can be employed in the implant                                                                                                    
                     other than the claimed solid bioactive polypeptide and lipid                                                                                                      
                     powder.        4                                                                      The legal standard for                                                      
                     definiteness under paragraph two of 35 U.S.C. § 112 is whether                                                                                                    
                     a claim reasonably apprises those of skill in the art of its                                                                                                      
                     scope.  See Amgen Inc. v. Chugai Pharmaceutical Co. Ltd., 927                                                                                                     


                                4    See the specification, page 8, lines 25-28, page 9, lines 13-25, and Examples                                                                     
                     1-5 on pages 11-21.                                                                                                                                               
                                                                                          5                                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007